Thus, to explore the characteristics of B cells in patients with gastric cancer, the percentage of CD19+B cells was analyzed in PBMCs, normal tissues, peritumoral tissues and tumor tissues using flow cytometry. This evidence concerns the gene CD19 and neoplasm.